Immune checkpoint proteins play an important role in regulating the immune system and preventing autoimmunity. Certain proteins, called checkpoint inhibitors, act as brakes on the immune system and allow cancer cells to avoid detection and destruction by the immune system. Research is exploring the use of drugs that target these checkpoint proteins like PD-1 and CTLA-4 to "release the brakes" on immune responses and enable the immune system to attack and eliminate cancer cells.
Immune checkpoint proteins play an important role in regulating the immune system and preventing autoimmunity. Certain proteins, called checkpoint inhibitors, act as brakes on the immune system and allow cancer cells to avoid detection and destruction by the immune system. Research is exploring the use of drugs that target these checkpoint proteins like PD-1 and CTLA-4 to "release the brakes" on immune responses and enable the immune system to attack and eliminate cancer cells.
Immune checkpoint proteins play an important role in regulating the immune system and preventing autoimmunity. Certain proteins, called checkpoint inhibitors, act as brakes on the immune system and allow cancer cells to avoid detection and destruction by the immune system. Research is exploring the use of drugs that target these checkpoint proteins like PD-1 and CTLA-4 to "release the brakes" on immune responses and enable the immune system to attack and eliminate cancer cells.